Related Experiment Video
Updated: Jan 18, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Going beyond SMILES enumeration for data augmentation in generative drug discovery
Helena Brinkmann1, Antoine Argante1, Hugo Ter Steege1
1Institute for Complex Molecular Systems (ICMS), Eindhoven AI Systems Institute (EAISI), Department of Biomedical Engineering, Eindhoven University of Technology Eindhoven The Netherlands f.grisoni@tue.nl.
Abstract:
Data augmentation can alleviate the limitations of small molecular datasets for generative deep learning by 'artificially inflating' the number of instances available for training. SMILES enumeration - wherein multiple valid SMILES strings are used to represent the same molecules - has become particularly beneficial to improve the quality of de novo molecule design. Herein, we investigated whether rethinking SMILES augmentation techniques could further enhance the quality of de novo design. To this end, we introduce four novel approaches for SMILES augmentation, drawing inspiration from natural language processing and chemistry insights: (a) token deletion, (b) atom masking, (c) bioisosteric substitution, and (d) self-training. Via systematic analysis, our results showed the promise of considering additional strategies for SMILES augmentation. Every strategy showed distinct advantages; for example, atom masking is particularly promising to learn desirable physico-chemical properties in very low-data regimes, and deletion to create novel scaffolds. This new repertoire of SMILES augmentation strategies expands the available toolkit to design molecules with bespoke properties in low-data scenarios.
Related Concept Videos
Drug Discovery: Overview
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Bioavailability Enhancement: Drug Solubility Enhancement
Analysis of Population Pharmacokinetic Data

